Most not too long ago, it has been discovered that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in identical regions as classical opioid receptors, it binds to a big range of endogenous opioids. As opposed to most opioid receptors, this receptor acts to be a scavenger and won't activate a 2nd messe… Read More